Rapid awakening followed active reversal within a monitored anesthetic plan.
The case described cochlear implantation in a patient with mitochondrial encephalomyopathy. Remimazolam and remifentanil were guided by monitoring. The report did not observe perioperative lactic acidosis or prolonged muscle relaxation, and consciousness returned after flumazenil.
One patient cannot establish comparative safety across heterogeneous mitochondrial disorders. Other drugs, metabolic preparation and monitoring shaped the course. Antagonist-assisted emergence cannot be interpreted as spontaneous clearance, and an uncomplicated procedure does not exclude every later effect.
For reviewing anesthesia in metabolic disease, examine physiological trends, baseline manifestations and co-medications. Keep the observed absence of specified complications separate from a universal safety claim. The report adds clinical experience while leaving optimal agent selection and dosing to broader evidence and individual assessment.
Source: Publication PMC8222447. Applications to expert review are interpretive analysis.
Related reading: Kampo-Assisted Benzodiazepine Reduction Was Reported in Two Uncontrolled Cases.